Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 double-blind confirmatory study of nifuratel + nystatin vaginal soft capsules versus Macmiror Complex for vaginitis
CTR20260526Phase 3Active
- Sponsor
- Beijing Jincheng Taier Pharmaceutical
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nifuratel, nystatin in Vulvovaginitis, vaginitis, trichomonal vaginitis, vulvovaginal candidiasis (VVC), bacterial vaginosis (BV), sponsored by Beijing Jincheng Taier Pharmaceutical. Started Feb 2026; status: active.
02
Drugs
nifuratelnystatin
03
Conditions
Vulvovaginitisvaginitistrichomonal vaginitisvulvovaginal candidiasis (VVC)bacterial vaginosis (BV)
Beyond the preview
Go deeper on CTR20260526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260526.